Verily partners with pharma giants, promising to 'transform clinical research'

The life sciences arm of Google-parent company Alphabet (Nasdaq: GOOGL), Verily, has announced that four of the world’s leading pharma companies have joined its Project Baseline initiative.

This project is aimed at engaging more patients and clinicians in research and speed evidence generation, and the companies that signed up to be part of it now include Novartis (NOVN: VX), Otsuka Pharmaceutical (TYO: 4578), Pfizer (NYSE: PFE) and Sanofi (Euronext; SAN).

"We have the opportunity to develop a new trial recruitment model"It is hoped that Verily’s strategic alliances with these drugmakers will lead to the development of digitally innovative, patient-centered clinical research programs using Project Baseline’s evidence generation platform and tools.